Reports for CIPROFLOXACIN INTRAVENOUS INFUSION BP
Brand name
CIPROFLOXACIN INTRAVENOUS INFUSION BP
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02304759 |
Ingredients
CIPROFLOXACIN |
Ingredient Strength
2 MG |
ATC Code
J01MA |
ATC Descriptor
QUINOLONE ANTIBACTERIALS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| CIPROFLOXACIN INTRAVENOUS INFUSION BP | 10LIIF | Resolved | 2024-09-05 | 2024-12-24 | 236746 |
| CIPROFLOXACIN INTRAVENOUS INFUSION BP | 10LIIF | Avoided shortage | 2024-09-05 | 2024-09-30 | 236750 |
| CIPROFLOXACIN INTRAVENOUS INFUSION BP | 10LIIF | Actual shortage | 2024-11-11 | 2025-01-13 | 242747 |
Showing 1 to 3 of 3
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0